Media Resources

Colors

For easy reference, CeQur corporate and product colors are:

Light Blue

HEX #00A3E1

RGB 0, 163, 225

Orange

HEX #FF671F

RGB 255, 103, 31

Yellow

HEX #FFB81C

RGB 255, 184, 28

Green

HEX #61A944

RGB 97, 169, 68

Navy

HEX #002F6C

RGB 0, 47, 108

Blue

HEX #006298

RGB 0, 98, 152

Gray

HEX #BBBCBC

RGB 187, 188, 188

Recent CeQur Company News

Press Release   >>  Jun 5, 2019


CeQur Appoints Bradley Paddock Chief Executive Officer CeQur® today announced that the journal Diabetic Medicine published the findings from two studies evaluating the company’s PAQ® Insulin Delivery Device among people with type 2 diabetes. The data demonstrate that the simple three-day, wearable PAQ basal-bolus insulin delivery device significantly improved glycemic control among people with type 2 diabetes who transitioned to the device. Study participants also reported increased treatment satisfaction with the PAQ basal-bolus insulin device as compared to insulin injections. Click here to download the press release.




Press Release   >>  March 18, 2019


CeQur Appoints Peter B. Luther to Board of Directors CeQur® announced the appointment of Peter B. Luther to its board of directors, effective immediately. Luther is a 29-year veteran of the medical device and diagnostics, OTC drugs and consumer-packaged goods industries. Click here to download the press release.




Press Release   >>  July 17, 2018


CeQur Acquires Assets from Calibra Medical, Inc. CeQur® today announced that the company has acquired select assets of Calibra Medical, Inc., one of the Johnson & Johnson Diabetes Care Companies. The transaction includes an exclusive worldwide license for the wearable, on-demand insulin delivery system previously known as OneTouch Via™. The Calibra system enables people with diabetes to discreetly and conveniently deliver rapid-acting insulin at mealtime. Click here to download the press release.




Newest Press Release


Click here to download the press release.





Media Kit

Our media kit is designed for the press and media. Rollover (or mobile tap) the images below and select the link for the format of the product images and logo you want. CeQur maintains all copyrights to these images and files. For more information please contact our Corporate Communications Office at media@cequr.com.

CeQur In The Media

#demo.question.question1#


#demo.question.question1.answer1#




#demo.question.question2#


#demo.question.question2.answer1#

  1. #demo.question.question2.answer2#
  2. #demo.question.question2.answer3#
  3. #demo.question.question2.answer4#
  4. #demo.question.question2.answer5#




#demo.question.question3#


#demo.question.question3.answer0#

  1. #demo.question.question3.answer1#
  2. #demo.question.question3.answer2#
  3. #demo.question.question3.answer3#
  4. #demo.question.question3.answer4#
  5. #demo.question.question3.answer5#




#demo.question.question4#


#demo.question.question4.answer1#





Product and Company Logos

Product Images

Recent CeQur Company News

Press Release   >>  Jun 5, 2019


CeQur Appoints Bradley Paddock Chief Executive Officer CeQur® today announced that the journal Diabetic Medicine published the findings from two studies evaluating the company’s PAQ® Insulin Delivery Device among people with type 2 diabetes. The data demonstrate that the simple three-day, wearable PAQ basal-bolus insulin delivery device significantly improved glycemic control among people with type 2 diabetes who transitioned to the device. Study participants also reported increased treatment satisfaction with the PAQ basal-bolus insulin device as compared to insulin injections. Click here to download the press release.




Press Release   >>  March 18, 2019


CeQur Appoints Peter B. Luther to Board of Directors CeQur® announced the appointment of Peter B. Luther to its board of directors, effective immediately. Luther is a 29-year veteran of the medical device and diagnostics, OTC drugs and consumer-packaged goods industries. Click here to download the press release.




Press Release   >>  July 17, 2018


CeQur Acquires Assets from Calibra Medical, Inc. CeQur® today announced that the company has acquired select assets of Calibra Medical, Inc., one of the Johnson & Johnson Diabetes Care Companies. The transaction includes an exclusive worldwide license for the wearable, on-demand insulin delivery system previously known as OneTouch Via™. The Calibra system enables people with diabetes to discreetly and conveniently deliver rapid-acting insulin at mealtime. Click here to download the press release.




Newest Press Release


Click here to download the press release.





CeQur In The Media

ADA Poster >> June 16, 2020


"High Treatment Satisfaction with 3-day Insulin Patch is Independent of Patient Demographics: A Post-Hoc Analysis" — a presentation at the American Diabetes Association 80th Scientific Sessions Click here to play the presentation. Click here to download the presentaion.




Article  >>  June 6, 2019


The Wider View: With new CEO in place, CeQur primed to PAQ a punch in diabetes market Click here to open an external link. ATTENTION: You will be leaving CeQur’s website. CeQur does not control the content of the website you are visiting.




Article   >>  June 5, 2019


CeQur CEO Robert Farra transitions to chief technology officer, succeeded by Bradley Paddock Click here to open an external link. ATTENTION: You will be leaving CeQur’s website. CeQur does not control the content of the website you are visiting.




Article  >>  July 19, 2018


Two New 'Wearable Pen' Insulin Devices Coming Soon Click here to open an external link. ATTENTION: You will be leaving CeQur’s website. CeQur does not control the content of the website you are visiting.